SCHEMBL17679293

SCHEMBL17679293

CC[C@@H](O)c1cccnc1C(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 1/20 0.38
LMNA P02545 3/20 0.37
HIF1A Q16665 2/20 0.35
CYP2C19 P33261 1/20 0.35
RIPK1 Q13546 1/20 0.33
KDM4E B2RXH2 3/20 0.32
NFKB1 P19838 2/20 0.32
KMT2A Q03164 2/20 0.32
ALDH1A1 P00352 1/20 0.32
ADRB2 P07550 1/20 0.32
ADRB1 P08588 1/20 0.32
CYP2D6 P10635 1/20 0.32
TSHR P16473 1/20 0.32
BLM P54132 1/20 0.31
MAPK1 P28482 2/20 0.31
HTT P42858 2/20 0.31
TDP1 Q9NUW8 2/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
MITF O75030 1/20 0.31
TP53 P04637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17679292 1.00 PDE2A (0.38) PDE2ALMNAHIF1ACYP2C19RIPK1
SCHEMBL7464555 0.85 HIF1A (0.34) HIF1ACYP2C19RIPK1KDM4ENFKB1
SCHEMBL22480736 0.81 HIF1A (0.55) LMNAHIF1ACYP2C19NFKB1KMT2A
SCHEMBL15927345 0.80 ALDH1A1 (0.34) PDE2ALMNAHIF1ACYP2C19KDM4E
SCHEMBL17679294 0.80 ALDH1A1 (0.34) PDE2ALMNAHIF1ACYP2C19KDM4E
SCHEMBL17681956 0.77 LMNA (0.41) PDE2ALMNAHIF1ACYP2C19KDM4E
SCHEMBL679872 0.77 LMNA (0.41) PDE2ALMNAHIF1ACYP2C19KMT2A
SCHEMBL17681986 0.77 LMNA (0.41) PDE2ALMNAHIF1ACYP2C19KDM4E
SCHEMBL28336015 0.77 LMNA (0.41) PDE2ALMNAHIF1ACYP2C19KDM4E
SCHEMBL20831318 0.76 LMNA (0.37) PDE2ALMNAHIF1ACYP2C19KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160102073-A1 2-HYDROXYMETHYL-SUBSTITUTED OREXIN RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2016-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160102073-A1 2-HYDROXYMETHYL-SUBSTITUTED OREXIN RECEPTOR ANTAGONISTS HCRTR2, HCRTR1, CRHR2 PDE2A 1887/4885LMNA 3412/4885HIF1A 248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.